Smaller portions could become more common on shelves, with inflation and GLP-1 appetite changes both pushing food makers toward personal packs.
Recap by typeshit. Post by Facebook on Facebook.
Kalkine Media ties the attention on Lilly to orforglipron's progress, arguing a pill could scale cheaper than injectables and ease supply limits.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
Oral Wegovy brought in about $850 million in H1 2026 and holds over 80% of new US oral scripts. Lilly says Foundayo volume doubled in a month.
Gottlieb also covers the FDA's new Rare Disease Framework Initiative and the latest on the measles outbreak in the CNBC interview.
Officers say the seized pharmaceuticals were worth $280,106.20 in total, part of a wider push against smuggled weight loss and peptide products.
The Form 483 cites microbial growth in a clean hood, reversed cleanroom air pressure and active ingredients marked for research use only. Check which pharmacy filled your vial.
Loading…